Patients must have total bilirubin =< 1.5 x IULN
Patients must have total bilirubin =< 2.5 x IULN
Direct bilirubin =< 1.5 x IULN (=< 5 x IULN if secondary to lymphoma) within 28 days prior to registration
Patients must have total bilirubin =< 2.0 x IULN within 14 days prior to registration
Total bilirubin =< 2.0 x IULN within 14 days prior to registration
Patients must have bilirubin =< 2 x IULN within 7 days prior to registration (unless the bilirubin is primarily unconjugated)
Total bilirubin =< 1.5 x the IULN
Serum total bilirubin =< 1.5 x IULN OR direct bilirubin =< IULN for patients with total bilirubin > 1.5 x IULN
Total bilirubin =< 1.5 x institutional upper limit of normal (IULN) OR direct bilirubin =< IULN for patients with total bilirubin > 1.5 x IULN
Bilirubin =< 1.5 x IULN
Bilirubin 1.5-2 x IULN
Total bilirubin =< 1.5 x international upper limit of normal (IULN) OR direct bilirubin =< IULN for patients with total bilirubin > 1.5 x IULN
Total bilirubin =< 1.5 x institutional upper limit of normal (IULN) OR direct bilirubin =< IULN for patients with total bilirubin > 1.5 x IULN
ARM B COHORT 3: Total bilirubin =< 1.5 x IULN
ARM C COHORT 4: Total bilirubin =< 2 X IULN
Total bilirubin < 3 x IULN
Total bilirubin =< 1.5 x IULN
Total bilirubin =< 1.5 x IULN
Total bilirubin =< 1.5 x IULN
Total bilirubin =< 1.5 x IULN
Total bilirubin < 1.5 x IULN
REGISTRATION #2 - PRIOR TO CONSOLIDATION CHEMOTHERAPY: Total bilirubin =< IULN
Total bilirubin =< 1.5 x IULN
Total bilirubin =< 1.5 x IULN within 14 days prior to Step 3 registration
Total bilirubin =< IULN; or total bilirubin =< 3.0 x IULN or direct bilirubin =< 1.5 ULN in patients with well documented Gilbert’s syndrome
Total bilirubin =< 1.5 x IULN
Total bilirubin =< 1.5 x institutional upper limit of normal (IULN) OR direct bilirubin =< IULN for patients with total bilirubin > 1.5 x IULN
Total bilirubin >= 2 x IULN